JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $415,685 | – | 31,563 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $383,949,162 | 5.08% |
| Logos Global Management LP | 750,000 | $31,417,500 | 2.55% |
| Cormorant Asset Management, LP | 1,050,000 | $43,984,500 | 2.54% |
| Paradigm Biocapital Advisors LP | 1,564,452 | $65,534,894 | 2.51% |
| Orbimed Advisors | 2,979,828 | $124,824,995 | 2.46% |
| Vestal Point Capital, LP | 725,000 | $30,370,250 | 2.26% |
| EcoR1 Capital, LLC | 1,469,818 | $61,570,676 | 1.88% |
| Avidity Partners Management LP | 840,219 | $35,196,774 | 1.50% |
| Ratan Capital Management LP | 105,757 | $4,430,160 | 1.34% |
| STEMPOINT CAPITAL LP | 92,949 | $3,893,634 | 1.14% |